| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |